Saturday, 5 March 2011

Biotechnology in Health- How to ensure growth

The obvious benefits of biotechnology for human health and life style has catapulted businesses and governments to join and create a positive framework for the industry to promote for the good of all.

The following measures can be taken by the mandarins of the captains of industry and reap the rewards of the great potential of the sector.

In the long term, the government support creative
Governments can encourage the biotech sector, providing incentives to overcome the difficult economic conditions. For example, Brazilian authorities faced with high rates of inflation and the Cuban authorities revised foreign investment laws. In reality, political will and a strong government role is essential for all countries with strengths in biotechnology. It 'the same model as the U.S. government has adopted several years ago. global high-tech industry of America in the biotechnology sector has been strongly supported by the government in almost all stages of its evolution. The loss of the most brilliant researchers and developed countries like the United States is a serious and continuing challenge for developing countries and governments can play an important role in stemming the "brain drain". Since the end of 1990, China has made concerted efforts to encourage expatriate professionals to return and contribute to research efforts. Incentives include the provision of funding for the creation of laboratories in China and programs that enable scientists to develop the business back. Similar trends were also noted in India, where a large number of NRIs returning to the country for growth opportunities and incentives offered in the country.

product specialization results of profitability:
By focusing on a specialized field is what is needed for developing countries. For example, recombinant vaccines are relatively easy to reproduce and can be much more cost-effective in the treatment of infectious diseases drug. India, for example, is developing vaccines for hepatitis B and C. With limited resources and underdeveloped private sector, targeted at specific sectors to meet both their needs and existing strengths is an effective strategy employed by some developing countries.

Private sector power products and services:
Initiate and support the growth of the private sector and the commercialization of scientific discoveries into products is what is needed. Private sector participation is essential to integrate several sources of knowledge in the field of biotechnology for health and their transformation into products and services.

Successful innovation requires collaboration:
Successful innovation requires collaboration and cooperation widespread. lack of cooperation from China has prevented its scientists to be the first in the world to sequence severe acquired respiratory syndrome (SARS).